Advertisement

Topics

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

08:09 EDT 23 Aug 2017 | Nature Publishing

Direct-acting antiviral agents (DAAs) are highly effective treatments for HCV, but are not always accessible to people who inject drugs (PWID). Here, Grebely and colleagues outline the epidemiology of HCV in PWID, discuss current data on DAA outcomes in this population and highlight steps required to broaden access to HCV therapy with the eventual goal of HCV elimination.

Original Article: Direct-acting antiviral agents for HCV infection affecting people who inject drugs

NEXT ARTICLE

More From BioPortfolio on "Direct-acting antiviral agents for HCV infection affecting people who inject drugs"

Advertisement
Quick Search
Advertisement
Advertisement